Perinatal Division, Helen Schneider's Hospital for Women, Rabin Medical Center, Petah-Tiqva, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Ann N Y Acad Sci. 2010 Sep;1205:88-93. doi: 10.1111/j.1749-6632.2010.05671.x.
The current diagnostic criteria for gestational diabetes mellitus are controversial because they lack correlation to maternal and perinatal outcome. The results of the hyperglycemia and adverse pregnancy outcome (HAPO) study demonstrate a linear association between increasing levels of fasting, 1- and 2-h plasma glucose post a 75 g oral glucose tolerance test to several significant outcome endpoints, such as birth weight above the 90th percentile, cord blood serum C-peptide level above the 90th percentile, primary cesarean delivery, clinical neonatal hypoglycemia, premature delivery, shoulder dystocia or birth injury, intensive neonatal care admission, hyperbilirubinemia, and preeclampsia. A consensus report by the IADPSG, based on a vigorous assessment of the HAPO results and other studies, recommended an endorsement of risk-based, internationally accepted criteria for the diagnosis and classification of diabetes in pregnancy. This review follows the steps from defining the problem to the endpoint of achieving a worldwide policy change.
目前的妊娠期糖尿病诊断标准存在争议,因为它们与母婴围产结局缺乏相关性。高血糖与不良妊娠结局(HAPO)研究的结果表明,在口服 75g 葡萄糖耐量试验后,空腹、1 小时和 2 小时血浆葡萄糖水平逐渐升高与多个重要结局终点之间存在线性关联,例如出生体重高于第 90 百分位数、脐血血清 C 肽水平高于第 90 百分位数、初次剖宫产、新生儿临床低血糖、早产、肩难产或产伤、新生儿重症监护病房收治、高胆红素血症和子痫前期。IADPSG 的一份共识报告根据对 HAPO 结果和其他研究的深入评估,建议采用基于风险的、国际公认的妊娠糖尿病诊断和分类标准。本综述遵循从定义问题到实现全球政策改变的步骤。